The role of the PLGF in the prediction of the outcome in pregnancies with a small for gestational age fetus
Authors:
- 14 October 2023
- journal article
- research article
- Published by Springer Nature in Archives of Gynecology and Obstetrics
- Vol. 310 (1) , 237-243
Abstract
Purpose To explore the value of measuring maternal serum PLGF in the prediction of the outcome of small for gestational age fetuses (SGA ). Methods Singleton pregnancies referred with suspicion of SGA in the third trimester were included if they had: no indication for nor signs of imminent delivery, fetal abdominal circumference (AC) at or below the 10th centile and/or estimated fetal weight (EFW) at or below the 10th centile and/or umbilical artery pulsatility index (Umb-PI) at or above the 90th centile for gestation. Women with pre-eclampsia at presentation were excluded. Maternal blood was drawn at the first (index) visit and analyzed retrospectively. Results Fifty-one fetuses were examined. Multiple regression analysis showed that family history of microsomia, index EFW and PLGF were significant predictors of the birthweight centile; index femur length centile and PLGF were significant predictors of pre-eclampsia; PLGF and index systolic blood pressure were significant predictors of iatrogenic preterm delivery < 37 weeks, whereas PLGF and index EFW were significant predictors of birthweight ≤ 5th centile and admission to the neonatal intensive care unit. For all outcomes, the addition of maternal–fetal parameters did not improve the prediction compared to PLGF alone. Using a cutoff of 0.3 MoM for PLGF would identify 94.1% of the pregnancies with iatrogenic preterm delivery and/or intra-uterine death and all of the cases that developed pre-eclampsia, for a screen positive rate of 54.9%. Women with PLGF ≤ 0.3 MoM had a poor fetal/maternal outcome (iatrogenic preterm delivery, pre-eclampsia, intra-uterine death) in 61.5% of cases. Conclusion In pregnancies complicated by SGA, PLGF identifies a very high-risk group that may benefit from intense surveillance.Keywords
This publication has 22 references indexed in Scilit:
- Fetal monitoring indications for delivery and 2‐year outcome in 310 infants with fetal growth restriction delivered before 32 weeks' gestation in the TRUFFLE studyUltrasound in Obstetrics & Gynecology, 2016
- Prediction of stillbirth from placental growth factor at 19–24 weeksUltrasound in Obstetrics & Gynecology, 2016
- PlGF in a clinical setting of pregnancies at risk of preeclampsia and/or intrauterine growth restrictionThe Journal of Maternal-Fetal & Neonatal Medicine, 2016
- Consensus definition of fetal growth restriction: a Delphi procedureUltrasound in Obstetrics & Gynecology, 2016
- Competing-risks model in screening for pre-eclampsia by maternal factors and biomarkers at 35-37 weeks' gestationUltrasound in Obstetrics & Gynecology, 2015
- Angiogenic factors at diagnosis of late-onset small-for-gestational age and histological placental underperfusionPlacenta, 2014
- Hypertension in PregnancyObstetrics & Gynecology, 2013
- Can placental growth factor in maternal circulation identify fetuses with placental intrauterine growth restriction?American Journal of Obstetrics and Gynecology, 2012
- Performance of third‐trimester ultrasound for prediction of small‐for‐gestational‐age neonates and evaluation of contingency screening policiesUltrasound in Obstetrics & Gynecology, 2011
- Shared and disparate components of the pathophysiologies of fetal growth restriction and preeclampsiaAmerican Journal of Obstetrics and Gynecology, 2006